Europe - OSL:MEDI - NO0010159684 - Common Stock
The current stock price of MEDI.OL is 260 NOK. In the past month the price increased by 14.04%. In the past year, price increased by 52.05%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABL.DE | ABBOTT LABORATORIES | 25.46 | 190.51B | ||
| IUI1.DE | INTUITIVE SURGICAL INC | 63.86 | 169.63B | ||
| 1ISRG.MI | INTUITIVE SURGICAL INC | 54.06 | 143.61B | ||
| BSX.DE | BOSTON SCIENTIFIC CORP | 34.57 | 130.10B | ||
| 1BSX.MI | BOSTON SCIENTIFIC CORP | 35.45 | 127.13B | ||
| 2M6.DE | MEDTRONIC PLC | 16.88 | 103.08B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 20.81 | 55.87B | ||
| BOX.DE | BECTON DICKINSON AND CO | 13.03 | 45.89B | ||
| EWL.DE | EDWARDS LIFESCIENCES CORP | 29.82 | 38.70B | ||
| DC4.DE | DEXCOM INC | 42.04 | 24.07B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 17.3 | 23.99B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 17.22 | 23.88B |
Medistim ASA engages in the development, manufacture, and distribution of medical equipment and consumables. The company is headquartered in Oslo, Oslo and currently employs 154 full-time employees. The company went IPO on 2004-05-28. The company develops, manufactures and distributes medical devices that measure blood flow and visualize atherosclerosis, and thereby help improve the outcome of cardiac and vascular surgery. The firm provides Transit Time Flow Measurement (TTFM) and ultrasound imaging to the global market to enable medical professionals to reduce risk and enhance quality of cardiac, vascular and transplant surgery. Medistim’s activities are divided into two business units: Own Products Category and Third-Party Products Category. Furthermore, the Company has several subsidiaries, including Medistim USA Inc, Medistim Norge AS and Medistim Japan KK.
MEDISTIM ASA
Okernveien 94
Oslo OSLO NO
Employees: 154
Phone: 4723059660
Medistim ASA engages in the development, manufacture, and distribution of medical equipment and consumables. The company is headquartered in Oslo, Oslo and currently employs 154 full-time employees. The company went IPO on 2004-05-28. The company develops, manufactures and distributes medical devices that measure blood flow and visualize atherosclerosis, and thereby help improve the outcome of cardiac and vascular surgery. The firm provides Transit Time Flow Measurement (TTFM) and ultrasound imaging to the global market to enable medical professionals to reduce risk and enhance quality of cardiac, vascular and transplant surgery. Medistim’s activities are divided into two business units: Own Products Category and Third-Party Products Category. Furthermore, the Company has several subsidiaries, including Medistim USA Inc, Medistim Norge AS and Medistim Japan KK.
The current stock price of MEDI.OL is 260 NOK. The price increased by 3.17% in the last trading session.
MEDISTIM ASA (MEDI.OL) has a dividend yield of 2.38%. The yearly dividend amount is currently 4.5.
MEDI.OL has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
MEDISTIM ASA (MEDI.OL) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on MEDI.OL.
MEDISTIM ASA (MEDI.OL) has a market capitalization of 4.77B NOK. This makes MEDI.OL a Mid Cap stock.
ChartMill assigns a technical rating of 9 / 10 to MEDI.OL. When comparing the yearly performance of all stocks, MEDI.OL is one of the better performing stocks in the market, outperforming 87.91% of all stocks.
ChartMill assigns a fundamental rating of 7 / 10 to MEDI.OL. MEDI.OL gets an excellent profitability rating and is at the same time showing great financial health properties.
Over the last trailing twelve months MEDI.OL reported a non-GAAP Earnings per Share(EPS) of 7.17. The EPS increased by 25.76% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 20.67% | ||
| ROA | 24.51% | ||
| ROE | 34.17% | ||
| Debt/Equity | 0.06 |
8 analysts have analysed MEDI.OL and the average price target is 260.1 NOK. This implies a price increase of 0.04% is expected in the next year compared to the current price of 260.
For the next year, analysts expect an EPS growth of 16.97% and a revenue growth 17.55% for MEDI.OL